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aTATE-OF-THE-ART PAPER169Exercise-Induced Troponin Releaseob Shave, Aaron Baggish, Keith George, Malissa Wood, Jurgen Scharhag, Gregory Whyte,
avid Gaze, Paul D. Thompson
ecent studies have documented elevations in cardiac troponin (cTn) following bouts of
ntense exercise in apparently healthy individuals. This state-of-the-art paper reviews the
iochemistry, prevalence, potential mechanisms, and management of patients with exercise-
nduced cTn elevations. As the majority of these data involve healthy individuals with no
nderlying cardiovascular disease, this is likely a benign process, although some studies have
ound accompanying transient cardiac dysfunction.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY1772-Year Follow-Up Confirms Superiority of FFR-Guided PCI0.70
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0 60 120 180 240 300 360 420 480 540 600 660 720ico H. J. Pijls, William F. Fearon, Pim A. L. Tonino, Uwe Siebert, Fumiaki Ikeno, Bernhard Bornschein,
arcel van’t Veer, Volker Klauss, Ganesh Manoharan, Thomas Engstrøm, Keith G. Oldroyd,
eter N. Ver Lee, Philip A. MacCarthy, Bernard De Bruyne, for the FAME Study Investigators
he FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study
howed that performing percutaneous coronary intervention (PCI) only in lesions with a
ractional flow reserve (FFR) 0.80 improves outcomes at 1 year compared with stenting all
esions that appear to be angiographically significant. This paper by Pijls and colleagues
eports on the 2-year outcomes of the FAME trial. Prior to randomization, lesions requiring
CI were identified based on their angiographic appearance. Patients were randomized to
ither have stenting of all indicated lesions or FFR-guided PCI for only those lesions with an
FR 0.80. The 2-year rates of mortality or myocardial infarction were significantly lower in
he FFR-guided group: 12.9% compared with 8.4%. In lesions deferred on the basis of an
FR 0.80, the subsequent rate of myocardial infarction was 0.2% and the revascularization
ate was 3.2% after 2 years. These results at 2 years confirm the superiority of an FFR-guided
pproach to PCI in subjects with multivessel coronary artery disease.(continued on page A-16)
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EYSPNEA AND ANTIPLATELET AGENTS
185yspnea Common With Ticagrelor:
Usually Mild, No Change in Ejection Fraction or Lung Function*
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*obert F. Storey, Kevin P. Bliden, Shankar B. Patil, Arun Karunakaran, Rosemary Ecob, Kathleen Butler,
enli Teng, Cheryl Wei, Udaya S. Tantry, Paul A. Gurbel, on behalf of the ONSET/OFFSET Investigators
icagrelor inhibits activation of the P2Y12 receptor reversibly. In clinical trials, some patients
reated with ticagrelor have reported dyspnea, but the mechanism is not known. Storey and
olleagues randomly assigned patients with stable coronary artery disease (CAD) to ticagrelor,
lopidogrel, or placebo. Electrocardiography, echocardiography, serum N-terminal pro-brain
atriuretic peptide, and pulmonary function tests were performed at baseline and after
weeks. Dyspnea was reported by 39%, 9.3%, and 8.3% of patients in the ticagrelor,
lopidogrel, and placebo groups, respectively. Most instances were mild and/or lasted 24 h,
lthough 3 patients discontinued ticagrelor due to dyspnea. There were no significant changes
n any of the cardiac or pulmonary function parameters. Dyspnea may be associated with
icagrelor therapy but the etiology remains unclear; the authors speculate that it involves
nhibition of adenosine uptake by erythrocytes.EART RHYTHM DISORDERS194Aggregate National Experience With the Wearable Cardioverter-Defibrillatorina K. Chung, Steven J. Szymkiewicz, Mingyuan Shao, Edwin Zishiri, Mark J. Niebauer,
ruce D. Lindsay, Patrick J. Tchou
he wearable cardioverter-defibrillator (WCD) is an external device capable of automatic
entricular tachycardia/ventricular fibrillation (VT/VF) detection and defibrillation. Chung
nd colleagues sought to determine the efficacy of the WCD in the “real-world.” Compliance
nd events were recorded in a nationwide registry. Of 3,569 patients who received the WCD,
he mean daily use was 19.9 h, with 71% of patients wearing the device 80% of the time.
here were 80 sustained VT/VF events in patients wearing the device. First shock success
as 76 of 76 (100%) for unconscious VT/VF, but 8 patients died after successful conversion.
systole occurred in 23 patients (17 died), representing 24% of sudden cardiac arrests. The
CD appears to be well-tolerated by patients and successfully treated VT/VF in 90% of
ases; a temporary pacemaker function may further improve efficacy.
ditorial Comment: Ralph J. Verdino, p. 204(continued on page A-19)
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wARDIAC IMAGING
206PECT Summed Stress Score Stratifies Sudden Death Risk in Patients
With LVEF >35%onathan P. Piccini, Aijing Z. Starr, John R. Horton, Linda K. Shaw, Kerry L. Lee, Sana M. Al-Khatib,
mi E. Iskandrian, Christopher M. O’Connor, Salvador Borges-Neto
iccini and colleagues sought to determine if single-photon emission computed tomography
SPECT) myocardial perfusion imaging (MPI) could predict the risk of sudden cardiac death
SCD) in patients with coronary artery disease (CAD) and left ventricular ejection fraction
LVEF) 35%. The study population included almost 5,000 patients with a median follow-
p of 6.5 years. During follow-up, there were 161 incidents of SCD (3.3%). After
ultivariable adjustment, each 3-U increase in the summed stress score (SSS) increased the
azard ratio for SCD by 1.13. Among patients with CAD and LVEF 35%, the extent of
tress MPI perfusion defect may be useful to predict the risk of SCD.ditorial Comment: Robert J. Myerburg, Robert C. Hendel, p. 215NDOTHELIAL FUNCTION218Flavanols Improve Endothelial Function and Mobilize Endothelial Progenitor Cellshristian Heiss, Sarah Jahn, Melanie Taylor, Wendy May Real, Franca S. Angeli, Maelene L. Wong,
icolas Amabile, Megha Prasad, Tienush Rassaf, Javier I. Ottaviani, Shirley Mihardja, Carl L. Keen,
atthew L. Springer, Andrew Boyle, William Grossman, Stanton A. Glantz, Hagen Schroeter,
erem Yeghiazarians
ietary flavanols can improve endothelial dysfunction, but the mechanism is not understood.
eiss and colleagues hypothesized that the mechanism would involve circulating angiogenic
ells (CACs), also termed endothelial progenitor cells, which are critical for vascular repair
nd maintenance of endothelial function. In a randomized, cross-over trial, 16 subjects with
table coronary artery disease received a high-flavanol supplement (HiFl) or nutrient-matched
ow-flavanol supplement (LoFl). Endothelium-dependent vasomotor function, as measured by
ow-mediated vasodilation, improved by 47% in the HiFl period compared with LoFl.
ollowing HiFl, the number of CD34/KDR-CACs increased 2.2-fold. Sustained
mprovements in endothelial dysfunction by regular dietary intake of flavanols are associated
ith mobilization of functional CACs.(continued on page A-20)
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225ncreased Liver Triglyceride Content Linked to Worse
Myocardial Perfusion, Altered Myocardial Metabolism in Diabeticsuuk J. Rijzewijk, Jacqueline T. Jonker, Rutger W. van der Meer, Mark Lubberink, Hugo W. de Jong,
ohannes A. Romijn, Jeroen J. Bax, Albert de Roos, Robert J. Heine, Jos W. Twisk, Albert D. Windhorst,
driaan A. Lammertsma, Johannes W. A. Smit, Michaela Diamant, Hildo J. Lamb
ijzewijk and colleagues investigated the relationship between hepatic triglyceride content and
oth myocardial function and metabolism in patients with type 2 diabetes mellitus. Patients
ere divided into 2 groups based on the triglyceride content of the liver as measured by
1H]-magnetic resonance spectroscopy. Those with high triglyceride content had decreased
nsulin sensitivity, reduced myocardial perfusion, reduced myocardial glucose uptake, and
educed myocardial phosphocreatine/adenosine triphosphate ratio. Cardiac fatty-acid
etabolism and left ventricular function were not different. The clinical implications of
epatic steatosis with respect to cardiac metabolism and function merit further study.NEWS FROM THE NHLBI EWS FROM THE NHLBI234NHLBI and the American Recovery and Reinvestment Act of 2009ichael S. Lauer
he 2009 American Recovery and Reinvestment Act (ARRA) was designed to stimulate the
iling American economy; the legislation included a $10.4 billion allocation to the National
nstitutes of Health (NIH). This report from Lauer explains how the National Heart, Lung,
nd Blood Institute (NHLBI) distributed the $763 million that it received as part of the
RRA. The 2 largest categories of spending were for grants to investigators who responded
o NIH-wide requests for applications ($351 million), and grants to 358 investigators who
ad previously submitted investigator-initiated research proposals that were highly meritorious
ut missed the payline ($292 million). Additional monies were spent to support research
mployment opportunities for young investigators and summer research experiences for
tudents and educators.
